Lumbosacral disc herniation is a common cause of chronic low back pain in
adults. Disc herniation induced pain is triggered by mechanical compression on
the dorsal root or ganglion of the herniated disc material or inflammation induced
by chemokines and enzymes in the disc(1). This pain is usually characterized by
pain arising in the back with or without radiation to lower limb in distribution in
one or more nerves.
Transforaminal epidural steroid injection (TFESI) involves instillation of
corticosteroids around the inflamed nerve root along with low concentration
solution of local anaesthetic . Fluoroscopy guided injection is given through the
intervertebral foramen into the ventral epidural space close to the pathological
site. This helps alleviate the pain by anti-inflammatory and neural membrane
stabilization effects of steroids, increase blood flow to ischemic spinal root
through local anaesthetic agent and removal of cytokines by washout effect of
injection(2,3) . This technique for treatment of lumbosacral radiculopathy is a
cost effective procedure in the majority of cases as compared to other operative
interventions. Complications associated with surgery such as recurrence,
cerebrospinal fluid leakage , haematoma and infections can be avoided . Despite
the established efficacy of TFESI for disc herniation related pain, successful
outcomes may not be obtained in all patients. There could be several variable
factors which might have an impact on treatment outcome in the immediate post
procedure period and later on. These factors could be patient related factors,
clinical or radiological findings. With the need to reduce low value healthcare it
would be helpful to be able to better identify patients who have a reasonable
chance of benefiting from ESI. Therefore this study aims to identify predictive factors for successful treatment outcome 3 months after TFESI in patients with
lumbosacral disc herniation induced pain. |